Homepage
Latest Videos
Latest Videos
Brightcove Home Latest Listing
Breast Cancer
Breast Cancer
Brightcove Cards Listing
Prostate Cancer
Brightcove Cards Listing
Multiple Myeloma
Multiple Myeloma
Brightcove Cards Listing
Popular on MedEnrich
Popular in No name
Myelodysplastic Syndromes14m 13s
ASH 2022 Update on Myelodysplastic Syndromes
ASH 2022 - Update on Myelodysplastic Syndromes
low risk mds
eln classification
low dose lenalidomide
viale -a
tags: azacitidine
venetoclax
1

ASH 2022 Update on Myelodysplastic Syndromes
Breast Cancer3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
her2 positive mbc
prolonged remission
trastuzumab duration
1

Duration of trastuzumab in patients with Her2...
Myelodysplastic Syndromes7m 3s
Clinical Application of Web Based Tool for Improving MDS Diagnosis
Gradient Based Model based on 10 routinely used parameters (Age, Gender, Hb, WBC, MCV, Platelets, Neutrophils, Monocytes, Glucose, Creatinine) is now available to facilitate non-invasive diagnosis of MDS.
mds
non-invasive diagnosis
1

Clinical Application of Web Based Tool for...
Breast Cancer14m 46s
ESMO 2022 Breast Cancer Comprehensive Coverage
View comprehensive coverage of Breast Cancer from ESMO 2022
dose dense adjuvant chemotherapy
esmo
keynote -522
monarch -3 study
1

ESMO 2022 Breast Cancer Comprehensive Coverage
Breast Cancer8m 50s
Immunotherapy of Early Breast Cancer
I-SPY2 clinical trial laid the foundation for Immunotherapy in Early Breast Cancer with Pembrolizumab added to Neoadjuvant Chemotherapy.
keynote -522
immunotherapy
early breast cancer
1

Immunotherapy of Early Breast Cancer
Breast Cancer11m 14s
Oral Selective Estrogen Receptor Degraders for ESR-1 Mutant Metastatic Breast Cancer
Endocrine therapy is the mainstay in the management of patients with Hormone receptor positive (ER+ve) Metastatic Breast Cancer. Tumor progression in ER+ve MBC could be attributed to genomic alterations such as ESR mutations.
biomarkers
esr1 mutation
fulvestrant
hormone receptor positive mbc
serd
1

Oral Selective Estrogen Receptor Degraders for...
OncoSpecials7m 52s
Treatment Free Remission in CML - Ready for Prime Time
TFR strategy is generally safe with adequate monitoring. Restarting TKI after loss of Major Molecular Response is safe with 80% of patients regaining MR4 after restarting TKI treatment.
treatment free remission
tfr
dasatinib
1

Treatment Free Remission in CML - Ready for Prime...
Multiple Myeloma4m 12s
Key Practice Points -Myeloma Related Renal Impairment
In patients with renal impairment primary goal is improvement of Renal Function which is associated with improved treatment outcomes. 50% of patients present renal impairment and renal impairment is severe in 15% of patients.
myeloma
renal impairment
key practice points
1

Key Practice Points -Myeloma Related Renal...
Pharmacy37m 20s
Quality management systems in pharmacy practice
Dr Scott Soefje, PharmD, Mayo Clinic
Provides a perspective “Quality Management Systems in Pharmacy Practice”.
Provides a perspective “Quality Management Systems in Pharmacy Practice”.
mednrich
1

Quality management systems in pharmacy practice
Multiple Myeloma6m 23s
Bone Targeted Treatments in Multiple Myeloma 2024-03-VD-EM-MMY-07
Long-term usage of bisphosphonates should be balanced with the potential of possible side-effects. Watch the detailed video on MedEnrich to learn about use of bone targeted agents, its dosage, frequency, optimal usage and limitations.
bisphosphonates
convenient agent
bone lesions
side-effects
1

Bone Targeted Treatments in Multiple Myeloma ...
For Pharmacist
For Pharmacist
Brightcove Cards Listing
Webinars
Webinar Cards Listing
MedBytes
MedBytes
Medbytes Cards Listing
Login
To get access to full MedEnrich experience, please Sign in
Don’t have an account? Register Now